| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |